Dalgety delivers the very best in laboratory grade growing practices to maintain consistent quality in our dried flower & extracts product range.
Our dedication to being a market leader in the UK pharma cannabis industry inspires us to set new standards in good practice and regulatory compliance.
From the very first day we have explored and tested the most innovative technology and methods to grow our products. We research, trial and develop our processes at all stages. As a result, our cannabis grows to standards well beyond accepted Good Agricultural & Cultivation Practice (GACP).
We are fully compliant with regulatory frameworks applicable to the production of medical API’s, cannabinoids and the growing of pharma grade cannabis. At this time we review and follow the parallel requirements of EU-GMP and UK cGMP. We will continue to apply and exceed current Good Manufacturing Practice (cGMP) to everything we do, from growing to final production.
Dalgety are compliant with requirements from MHRA (Medicines and Healthcare products Regulatory Agency) and the Home Office.
Dalgety continue to go above and beyond, from state-of-the-art security in our growing facility, regular and consistent batch testing of our product, to maintaining detailed audit trails for every plant and product produced. Our investment in the future growth of Dalgety reflects our firm belief in the future of cannabis for pain and health treatments.